ReviewHaematologica2019

Which are the most promising targets for minimal residual disease-directed therapy in acute myeloid leukemia prior to allogeneic stem cell transplant?

Brian Ball et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.